Unfolded protein response regulates P53 expression in the pulmonary endothelium

被引:36
作者
Akhter, Mohammad S. [1 ]
Uddin, Mohammad A. [1 ]
Barabutis, Nektarios [1 ]
机构
[1] Univ Louisiana Monroe, Coll Pharm, Sch Basic Pharmaceut & Toxicol Sci, 1800 Bienville Dr, Monroe, LA 71201 USA
关键词
acute lung injury; acute respiratory distress syndrome; endothelial barrier; inflammation; BARRIER FUNCTION; ER-STRESS; INFLAMMATION; CELLS; HSP90; ARDS;
D O I
10.1002/jbt.22380
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lung endothelial barrier dysfunction leads to severe pathologies, including the lethal Acute Respiratory Distress Syndrome. P53 has been associated with anti-inflammatory activities. The current study employs a variety of unfolded protein response (UPR) activators and inhibitors to investigate the regulation of P53 by UPR in lung cells. The bovine cells that were exposed to the UPR inductors brefeldin A, dithiothreitol, and thapsigargin; demonstrated elevated expression levels of P53 compared to the vehicle-treated cells. On the contrary, the UPR inhibitors N-acetyl cysteine, kifunensine, and ATP-competitive IRE1 alpha kinase-inhibiting RNase attenuator; produced the opposite effects. The outcomes of the present study reveal a positive regulation between UPR and P53. Since it has been shown that a mild induction of the unfolded protein response opposes inflammation, we suggest that P53 is involved in those protective activities in the lung.
引用
收藏
页数:5
相关论文
共 29 条
  • [1] Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?
    Altabas, V.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [2] Targeting the Endoplasmic Reticulum Unfolded Protein Response to Counteract the Oxidative Stress-Induced Endothelial Dysfunction
    Amodio, Giuseppina
    Moltedo, Ornella
    Faraonio, Raffaella
    Remondelli, Paolo
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [3] P53, GHRH, inflammation and cancer
    Barabutis, Nektarios
    Schally, Andrew V.
    Siejka, Agnieszka
    [J]. EBIOMEDICINE, 2018, 37 : 557 - 562
  • [4] Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition
    Barabutis, Nektarios
    Dimitropoulou, Christiana
    Gregory, Betsy
    Catravas, John D.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (03) : 1792 - 1804
  • [5] Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction
    Barabutis, Nektarios
    Khangoora, Vikramjit
    Marik, Paul E.
    Catravas, John D.
    [J]. CHEST, 2017, 152 (05) : 954 - 962
  • [6] Regulation of pulmonary endothelial barrier function by kinases
    Barabutis, Nektarios
    Verin, Alexander
    Catravas, John D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2016, 311 (05) : L832 - L845
  • [7] p53 protects against LPS-induced lung endothelial barrier dysfunction
    Barabutis, Nektarios
    Dimitropoulou, Christiana
    Birmpas, Charalampos
    Joshi, Atul
    Thangjam, Gagan
    Catravas, John D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 308 (08) : L776 - L787
  • [8] Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro
    Boehme, Kathleen
    Dietz, Yasmin
    Hewitt, Philip
    Mueller, Stefan O.
    [J]. TOXICOLOGY LETTERS, 2010, 198 (02) : 272 - 281
  • [9] Potential role of HSP90 in mediating the interactions between estrogen receptor (ER) and aryl hydrocarbon receptor (AhR) signaling pathways
    Chang, Ziwei
    Lu, Ming
    Kim, So-Sun
    Park, Jang-Su
    [J]. TOXICOLOGY LETTERS, 2014, 226 (01) : 6 - 13
  • [10] Dries David J, 2019, Air Med J, V38, P64, DOI 10.1016/j.amj.2018.12.003